Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") was established in 1997. It is a modern pharmaceutical enterprise controlled by China National Nuclear Uranium Co., Ltd., with its headquarters located in Luancheng District, Shijiazhuang City. After 26 years of development, the Company has become an important domestic manufacturer of chemical APIs, with its production scale ranking among the top in the industry. It currently has two wholly-owned subsidiaries: Hebei Shengxue Dacheng Tangshan Pharmaceutical Co., Ltd. and Hebei Hongcheng Yaxin Technology Co., Ltd., as well as one equity-participated company: Inner Mongolia Shengxue Dacheng Pharmaceutical Co., Ltd. The Company operates four production bases covering a total area of approximately 720,000 square meters and employs more than 1,500 people.
Exceeding Industry Benchmarks
24/7 Expert Consultation
Logistics Network Across 50+ Regions
Advanced Automated Synthesis Lines
Our multiple production lines are managed through automated control systems to ensure exact stoichiometric accuracy and batch-to-batch consistency.
We maintain a strategic reserve of high-grade precursors, sourced from verified suppliers to guarantee stable production schedules.
Continuous R&D integration allows us to refine manufacturing workflows, reducing waste and improving energy efficiency in all chemical processes.
The company operates four core business segments: API, animal health preparations, healthcare products and pet pharmaceuticals.With an annual output value of over 1 billion yuan across all product lines, around 50% of its products are sold for export each year.The company has established a quality management target system in compliance with pharmaceutical quality control requirements.All leading products have obtained domestic GMP certification, as well as U.S. FDA and EU CEP certifications, ranking among the industry’s top tier in terms of high-end international certification qualifications.